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ABSTRACT 
The hypoglycaemic efficacy of aqueous seed extract of Aframomum melegueta was investigated in alloxan-
induced diabetic rats. Twenty five albino rats (Rattus novergicus, average weight: 150g) were randomly 
divided into five groups of five (5) rats each. For the diabetic group, diabetes mellitus was induced by 
intraperitoneal injection of 5% solution of alloxan at a dose of 150 mg/kg body weight. Diabetes was 
confirmed 72 hours after alloxan injection if fasting blood glucose (FBG) was ≥ 10 mmol/l. Two control 
groups: non-diabetic (positive) and diabetic (negative) were administered tap water as vehicle solvent, 
throughout the duration of the experiment. The remaining three groups received 100 mg/kg of metformin, 
200 and 400 mg/kg orally and aqueous seed extract of Aframomum melegueta respectively and 
simultaneously. Fasting blood glucose was evaluated daily. The results showed that oral administration of 
aqueous extract of A. melegueta to diabetic rats lowered blood glucose to normal level within 6 days of 
administration, while metformin took 14 days. There was no significant difference in the duration of lowering 
the blood glucose by the two doses of extract administered. In conclusion, oral administration of aqueous 
seed extract of Aframomum melegueta has potent hypoglycaemic activity in alloxanised diabetic rats. 
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INTRODUCTION 
Diabetes mellitus is a metabolic disorder 
characterised by hyperglycaemia and alteration in 
carbohydrate, fat and protein metabolism and it is 
associated with absolute or relative deficiencies in 
insulin secretion or insulin action (Bhupesh et al., 
2009). The incidence of diabetes has reached an 
epidemic proportion worldwide. It is estimated that 
about 2.8% of the world’s population suffer from 
diabetes, according to World Health Organisation 
(Wild et al., 2004). The incidence is increasing 
rapidly and it is anticipated that by the year 2030, 
it will double the current figure (Ghost et al., 
2004). This rapid increase in the incidence of the 
disease is associated with rapidly changing 
lifestyle and environmental factors (Lang et al., 
2008; Mozaffarian et al., 2009).  
 
The use of herbal medicine is widespread 
throughout the world. Many medicinal plants have 
been confirmed to have hypoglycaemic 
properties. Some of them include Pterocarpus  
massupum (Indian Kino), Allium sativium (Garlic), 
Azadirachta indica (Neem), Carica papaya (unripe 
fruit), Trigonella foerum (Fenugreek), Ocimum 
santum (Tulsi), Aloe barbadensis miller 
(Adesokan et al,. 2006; Akinola, 2010). 
Aframomum melegueta is an herbaceous 
perennial plant species of the ginger family that is 
native to the swampy habitats along the West 
African coast. The Aframomum plant is trumpet-
shaped with purple flowers that develop into 5-7 
cm long with numerous reddish-brown seeds. 
Depending on the country, it is called several 
names including grains of paradise, melegueta 
pepper, alligator pepper and Guinea pepper.  
 
In Nigeria, it is called ata ire (Yoruba), and chitta 
(Hausa). It has been established to be a potent 
antimicrobial agent (Stroev, 1989); effective as an 
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antifungal (Okigbo and Ogbonnaya, 2006) and 
used to treat dysentery and diarrhoea (Stroev, 
1989). The seed is also used in treating 
inflammatory conditions of the throat, fever and 
exanthemata (Apata, 1979); snake bites (Nebojsa 
et al., 2009) and has antioxidant and antitumor 
effects (Chan et al., 2004). Although, the anti-
diabetic effectiveness of Aframomum melegueta 
is acclaimed traditionally (Gbolade, 2009), there 
is no proven scientific evidence to ascertain this. 
This study reports on the anti-diabetic potential of 
aqueous seed extract of Aframomum melegueta 
in alloxan-induced diabetic rats. 
 
MATERIALS AND METHODS 
Plant Material 
The seeds of Aframomum melegueta were 
obtained from Oja-Oba market, Ilorin and were 
authenticated in the Department of Plant Biology, 
University of Ilorin, Ilorin, Nigeria. 
 
Preparation of Seed Extract 
Seeds of A. melegueta were washed with water 
and air-dried under the shade to constant weight. 
The seeds were ground into powdery form with an 
electric blender (model MS- 223). The 20g of the 
powdered seed was soaked in 100ml of distilled 
water with constant stirring by a magnetic stirrer 
for 48 hours. It was filtered with muslin cloth and 
the filtrate evaporated in a water bath at 40
o
C. 
0.4g of the extract yielded 2% of 20g and was 
stored in a refrigerator at 8
o
C, from where stock 
solution was prepared. 
 
Experimental Animals 
Twenty five albino rats (Rattus novergicus) of both 
sexes and with an average weight of 150+2g, 
were obtained from the Small Animal Holding Unit 
of the Department of Biochemistry, University of 
Ilorin, Ilorin, Nigeria. They were exposed to 12 
hour daylight and 12 hour darkness, fed rat chew, 
water ad libitum, and were allowed to acclimatise 
for two weeks. They were randomly separated 
into five groups of 5 rats each according to their 
sexes. Group A which served as positive control, 
was given distilled and diabetes was not induced. 
Group B which served as the negative control, 
had diabetic induced and was left untreated. 
Group C also developed diabetes and was 
treated with 100 mg/kg body weight of anti-
diabetic drug, metformin, (Hovid, Bhd, Ipoh, 
Malaysia) procured from a registered pharmacy 
shop within Ilorin metropolis. Groups D and E 
were induced diabetes and treated with 200 and 
400 mg/kg body weight of aqueous seed extract 
of Aframomum melegueta respectively, based on 
preliminary studies. All the albino rats were kept 
under laboratory conditions (25+2
o
C and relative 
humidity of 50+15%) and their cages were 
cleaned of metabolic waste twice daily. 
 
Induction of Diabetes Mellitus 
Diabetes was induced by intraperitoneal injection 
of 5% aqueous solution of alloxan at a dose of 
150 mg/kg body weight. Alloxan (2,4,5,6-
tetraoxypyrimidine; 2,4,5,6-pyrimidine tetrone), is 
an oxygenated pyrimidine derivative and a toxic 
glucose analogue, which specifically destroys 
insulin producing β-cells of the pancreas. It 
therefore causes insulin dependent diabetes 
mellitus (IDDM). Fasting blood glucose was 
determined in each rat prior to the injection of 
alloxan to exclude those that could be naturally 
diabetic. Diabetes was confirmed if fasting blood 
glucose was ≥10 mmol/L. 
 
Determination of Blood Glucose 
Fasting blood glucose was determined by glucose 
oxidase method using Accu chek glucometer 
(Roche diagnostics, Germany). The tail of the rat 
was cut swiftly with sterile scalpel and a drop of 
blood was squeezed onto the test area of strip 
inserted into the glucometer. The animals were 
fasted for 12 hours before each glucose 
determination, which was repeated every 48 hrs 
till the end of the experiment. 
 
Statistical Analysis 
All values were expressed as mean +SD and the 
means were subjected to two way analysis of 
variance using the software – SPSS. P values of 
<0.05 were considered statistically significant. 
 
RESULTS 
The normal control (positive) group remained 
normoglycaemic throughout the duration of the 
experiment, while the negative control group B 
became hyperglycaemic 72 hrs after alloxan 
injection and remained so for 10 days, before all 
the animals died. Group C, that received 
metformin, showed gradual reduction of blood 
glucose and became normoglycaemic by the 14
th
 
day. The test groups D and E that received 200 
and 400 mg/kg body weight of aqueous seed 
extract of A. melegueta respectively, showed 
rapid reduction of blood glucose that returned to 
normal within 6 days. The two extract doses did 
not show any difference in the rate and duration 
of reduction of blood glucose, meaning that the 
effect was not dose dependent. These results are 
summarised in Table 1. 
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Table 1: Fasting Blood Glucose Concentrations (mmol/L) of Control Groups and those Administered 
Metformin and Aqueous Seed Extract of Aframomum melegueta in Alloxan Induced-diabetic Rats 
 






Normal: Control   
Group A 
5.27+0.25 5.27+0.25 5.27+0.25 5.27+0.25 5.27+0.25 5.27+0.25 5.27+0.25 5.27+0.25 
Diabetic: Control 
Group B 




23.81+0.01 18.67+0.01 17.12+0.01 11.70+0.00 9.46+0.01 7.12+0.01 5.74+0.00 4.52+0.01 
A.melegueta 200 
mg/kg: Group D 
25.89+0.02 17.19+0.01 11.10+0.00 4.74+0.01  4.74+0.01 4.74+0.01 4.74+0.01 4.74+0.01 
A.melegueta 400 
mg/kg: Group E 
23.58+0.00 14.45+0.00 10.03+0.01 4.95+0.01 4.95+0.01 4.95+0.01 4.95+0.01 4.95+0.01 
 
DISCUSSION 
This study, scientifically confirmed the locally 
acclaimed glucose lowering effect of aqueous 
seed extract of Aframomum melegueta by 
traditional medicine practitioners. The extract 
possesses a more potent hypoglycaemic property 
than metformin. It took 14 days to attain 
normoglycaemia in the group that received 
metformin and only 6 days in the two groups that 
received extract of A. melegueta. The 
hypoglycaemic effect of the plant extract could be 
insulinotropic, since alloxan induced 
hyperglycaemia, by causing insulin dependent 
diabetes mellitus (IDDM), or may be due to a 
combination of inhibition of hepatic glycogenolysis 
and gluconeogenesis (Chattopadyhyay, 1999). 
Metformin causes hypoglycaemia by delaying 
glucose uptake from gastrointestinal tract, 
increase peripheral glucose utilisation mediated 
by increased insulin sensitivity; inhibits hepatic 
and renal gluconeogenesis (Clark and Pierce, 
2000).  
 
Metformin has also been shown to reduce low 
density lipoprotein cholesterol and triglyceride 
levels, and prevent cardiovascular complications 
associated with diabetes (Clark and Pierce, 
2000). Conversely, the observed hypoglycaemic 
effect of the plant extract could be insulinotropic 
(Dunstan et al., 2002), since alloxan induced 
hyperglycaemia, by causing insulin dependent 
diabetes mellitus (IDDM), or may be due to a 
combination of inhibition of hepatic glycogenolysis 
and gluconeogenesis (Chattopadyhyay, 1996; 
1999). The fact that insulin is completely absent in 
alloxan-induced diabetes, perhaps explain the 
reason the extract of A. melegueta is more 
efficient than metformin. Earlier workers have 
however identified gingerols and related 
compounds in A. melegueta, which may be 
responsible for its hypoglycaemic property 
(Bhupesh et al., 2009). Essential oil, paradol, 
among others, is the active flavour constituent of 
A. melegueta, that has been found to possess 
antioxidant and antitumor properties (Chan et al., 
2004).  
 
In conclusion, the plant Aframomum melegueta 
can be of immense use in phytomedicine 
especially for the management of diabetes 
mellitus. This is a preliminary study and further 
studies on precise mechanism of action of the 
plants in reducing hyperglycaemia would be 
necessary. It would also be worthwhile to isolate 
the acclaimed active ingredients responsible for 
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